H441 lung cancer cells were pretreated with or without EGFR inhibitor in the presence of MART-1 (M27) peptide or CMV pp65 protein-derived control peptide, and used as target cells for Mart-1/HLA-A2 specific CTL in standard CTL assay. This evidence concerns the gene EGFR and lung cancer.